Translational Development Acquisition Corp
TDAC
30 hedge funds and large institutions have $112M invested in Translational Development Acquisition Corp in 2025 Q1 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
64.7% more ownership
Funds ownership: 0% → 64.7% (+65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$11M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$8.04M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$8.04M |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$7.71M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$6.53M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citadel Advisors
Miami,
Florida
| $176K | +$176K | +17,479 | New |
|
27
Geode Capital Management
Boston,
Massachusetts
| $166K | +$166K | +16,486 | New |
|
28
Morgan Stanley
New York
| $31.1K | +$31K | +3,082 | New |
|
|
CS
29
Clear Street
New York
| $29.8K | +$29.7K | +2,957 | New |
|
30
UBS Group
Zurich,
Switzerland
| $192 | +$191 | +19 | New |
|
TDAC Hedge Fund Activity: Q1 2025 in Review
30 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in Translational Development Acquisition Corp (TDAC) for Q1 2025, worth a combined $112M.
Buyers outnumbered sellers: 30 funds opened new TDAC positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AQR Arbitrage, opening a new position worth an estimated $11M.
- 30 institutional investors held Translational Development Acquisition Corp (TDAC) as of Q1 2025, up from 0 in Q4 2024.
- Funds reported $112M of Translational Development Acquisition Corp stock for Q1 2025.
- 30 funds opened new Translational Development Acquisition Corp positions in Q1 2025 and 0 closed out, a net change of +30 holders.
- The largest Translational Development Acquisition Corp buyer in Q1 2025 was AQR Arbitrage, an estimated $11M added.
Based on aggregated 13F filings for Q1 2025.